0001104659-24-026162.txt : 20240221 0001104659-24-026162.hdr.sgml : 20240221 20240221190334 ACCESSION NUMBER: 0001104659-24-026162 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240216 FILED AS OF DATE: 20240221 DATE AS OF CHANGE: 20240221 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meeker David P CENTRAL INDEX KEY: 0001385155 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38223 FILM NUMBER: 24661711 MAIL ADDRESS: STREET 1: C/O PENWEST PHARMACEUTICALS CO STREET 2: 39 OLD RIDGEBURY ROAD SUITE 11 CITY: DANBURY STATE: CT ZIP: 06810 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001649904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 462159271 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857-264-4280 MAIL ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: RHYTHM METABOLIC, INC. DATE OF NAME CHANGE: 20150803 4 1 tm246920-7_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-02-16 0 0001649904 RHYTHM PHARMACEUTICALS, INC. RYTM 0001385155 Meeker David P C/O RHYTHM PHARMACEUTICALS, INC. 222 BERKELEY STREET, 12TH FLOOR BOSTON MA 02116 1 1 0 0 President and CEO 0 Common Stock 2024-02-16 4 A 0 99000 0 A 220099 D Restricted Stock Units 2024-02-16 4 A 0 85000 0 A Common Stock 85000 85000 D Stock Option (Right to Buy) 49.23 2024-02-16 4 A 0 259000 0 A 2034-02-15 Common Stock 259000 259000 D The Issuer previously granted the Reporting Person an award of restricted stock units that vest based on the Issuer's satisfaction of certain performance objectives. On February 16, 2024, the Board determined that the performance condition had been satisfied. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date. The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. /s/ Hunter C. Smith, Attorney-in-Fact for David P. Meeker 2024-02-21